Your Messages Inbox
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Fda extends review of arzerra (ofatumumab)
Genmab, 06/18/09
GlaxoSmithKline and Genmab A/S announced that the United States Food and Drug Administration (FDA) informed the companies that the agency has extended the action date for the ofatumumab BLA application by three months.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Watson Files FDA Application for Generic Rozerem
Watson Pharmaceuticals, 12/07/09
Bristol-Myers Squibb And Pfizer Announce Plans To Submit Regulatory Filing For Apixaban In Europe
Bristol Myers-Squibb Company, 12/07/09
Non-safety-related voluntary recall of a limited portion of Daytrana (methylphenidate transdermal system) patches announced
Shire, 12/07/09
Article Search
Sponsor